145 related articles for article (PubMed ID: 10917138)
1. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests.
Díez-Martín JL; Buño I; Llamas P; Gosálvez J; López-Fernández C; Polo N; Regidor C
Cancer Detect Prev; 2000; 24(2):169-72. PubMed ID: 10917138
[TBL] [Abstract][Full Text] [Related]
2. Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods.
Testoni N; Lemoli RM; Martinelli G; Carboni C; Pelliconi S; Ottaviani E; Ruggeri D; Rizzi S; Motta MR; Visani G; Tura S
Bone Marrow Transplant; 1998 Dec; 22(11):1065-70. PubMed ID: 9877268
[TBL] [Abstract][Full Text] [Related]
3. What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Medical Research Council Leukaemia Working Parties.
Grimwade D; Walker H; Oliver F; Wheatley K; Clack R; Burnett A; Goldstone A
Bone Marrow Transplant; 1997 Jun; 19(11):1117-23. PubMed ID: 9193755
[TBL] [Abstract][Full Text] [Related]
4. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
[TBL] [Abstract][Full Text] [Related]
5. Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation.
Testoni N; Martinelli G; Zaccaria A; Miggiano MC; Pelliconi S; Visani G; Manfroi S; Gherlinzoni F; Mangianti S; Tura S
Bone Marrow Transplant; 1996 Dec; 18(6):1141-5. PubMed ID: 8971385
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations characteristic for sAML/sMDS are not detectable by random screening using FISH in peripheral blood-derived grafts used for autologous transplantation.
Weber MH; Wenzel U; Thiel E; Knauf WU
J Hematother Stem Cell Res; 2000 Dec; 9(6):861-5. PubMed ID: 11177598
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic characterization of acute myeloid leukemia in Shwachman's syndrome. A case report.
Spirito FR; Crescenzi B; Matteucci C; Martelli MF; Mecucci C
Haematologica; 2000 Nov; 85(11):1207-10. PubMed ID: 11064470
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
Nylund SJ; Ruutu T; Saarinen U; Larramendy ML; Knuutila S
Leukemia; 1994 Apr; 8(4):587-94. PubMed ID: 8152255
[TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplantation in myelodysplastic syndromes.
de Witte T; Suciu S; Brand R; Muus P; Kröger N
Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
[TBL] [Abstract][Full Text] [Related]
14. [Clonal analysis by fluorescence in situ hybridization in a patient with de nove acute myeloid leukemia with myelodysplasia].
Hyakuna N; Naritomi K; China K; Gushiken T; Tohma T; Ito E
Rinsho Ketsueki; 1997 Sep; 38(9):776-81. PubMed ID: 9364870
[TBL] [Abstract][Full Text] [Related]
15. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
16. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A
J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation.
Scaravaglio P; Guglielmelli T; Giugliano E; Marmont F; Audisio E; Gallo E; Saglio G; Rege-Cambrin G
Cancer Genet Cytogenet; 2002 Feb; 133(1):98-101. PubMed ID: 11890999
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
19. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
